CIK 0001867096 · Large accelerated filer
Xeris Biopharma Holdings, Inc.
Sign in to watch- Ticker
- XERS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 871082097
- Phone
- 844-445-5704
- Business address
- 1375 WEST FULTON STREET, SUITE 1300, CHICAGO, IL, 60607
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,678,894
- in 11 filings, $1.7M under 10b5-1 plans
Net −$1,678,894. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-13 | McCulloch Kevin See Remarks | Purchase | +25,000 | $4.38 | $109K | 1,708,585 |
| 2024-08-12 | Schmid John P. Director | Purchase | +4,515 | $2.25 | $10K | 25,200 |
| 2024-08-09 | Schmid John P. Director | Purchase | +4,285 | $2.37 | $10K | 20,685 |
| 2024-05-10 | Schmid John P. Director | Purchase | +5,400 | $1.91 | $10K | 16,400 |
| 2024-03-14 | Schmid John P. Director | Purchase | +4,500 | $2.16 | $10K | 11,000 |
Page 1 of 1 · 5 trades